You are here

  • Home
  • Archive
  • Volume 8, Issue 2
  • Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B

Article metrics

Article menu
XML
Oncolytic and local immunotherapy
Original research
Therapeutic efficacy and safety of a human fusion construct targeting the TWEAK receptor Fn14 and containing a modified granzyme B

 

Online download statistics by month:

Online download statistics by month: September 2020 to July 2025

AbstractFullPdf
Sep 202022322380
Oct 202010710754
Nov 2020383821
Dec 2020313117
Jan 2021454520
Feb 2021343415
Mar 2021404016
Apr 2021414113
May 2021313114
Jun 202137378
Jul 2021252514
Aug 202119195
Sep 2021383819
Oct 2021414127
Nov 2021585836
Dec 2021343412
Jan 2022303218
Feb 202214148
Mar 2022929226
Apr 2022424617
May 2022404019
Jun 2022525617
Jul 2022323424
Aug 2022373725
Sep 2022434376
Oct 2022384028
Nov 2022252521
Dec 2022191912
Jan 2023161611
Feb 2023525314
Mar 2023363830
Apr 2023293021
May 2023272712
Jun 2023202013
Jul 2023202010
Aug 202313145
Sep 2023222210
Oct 2023344022
Nov 2023313110
Dec 2023333412
Jan 2024282912
Feb 2024282814
Mar 2024292971
Apr 2024333334
May 2024464622
Jun 2024313117
Jul 2024575834
Aug 2024282894
Sep 2024171719
Oct 2024404084
Nov 2024434827
Dec 2024363725
Jan 2025424221
Feb 2025424238
Mar 2025343423
Apr 2025404023
May 2025444435
Jun 2025222222
Jul 2025110
Total228023141447